Furthermore, we investigated the role of this chemokine as a tumor response marker, as it has been suggested that CCL18 concentrations correlate with survival time in adenocarcinomas of the lung[22] but also in other malignancies [23]. Here, CCL18 is linked to lung adenocarcinoma.